Provision Language
Section B: General Terms and Conditions
31. Warranties, Limitations, Indemnification and Insurance
[…]
d. Insurance: Portfolio Company will maintain insurance coverage sufficient to cover the activities, risks, and potential omissions of the Portfolio Company Statement of Work in accordance with generally-accepted industry standards and as required by law. Portfolio Company will ensure that its subgrantees and subcontractors maintain insurance coverage consistent with this section.
Section C: CARB-X Special Terms and Conditions
Article V: Stewardship and Access plus Additional Obligations
[…]
5.03 Research and Development Standards and Development Diligence
(a) The Portfolio Company shall comply with all of the following standards at all times during the Project:
[…]
(iii) Where the Portfolio Company is undertaking research involving human participants, the Portfolio Company is required to have the relevant regulatory and ethical approvals and appropriate governance mechanisms in place before such research begins. It is the responsibility of the Portfolio Company (not Managing Entity) to ensure these approvals are received and that appropriate compensation arrangements (including insurance or indemnity cover, where available) are in place to cover research participants or their dependents against injuries or damage caused as a result of their participation in research, in accordance with local law and best practices. Managing Entity will not fund the costs of such insurance or indemnity cover, and will not be liable for any such compensation;
Attachment 5: Other Funder Terms and Conditions
Bill and Melinda Gates Foundation (“Foundation”)
COMPLIANCE. If the Agreement Scope of Work involves any trial involving human subjects, Portfolio Company will adhere to current Good Clinical Practice as defined by the International Council on Harmonisation (ICH) E-6 Standards (or local regulations if more stringent) and will obtain applicable trial insurance.